Vimpat 10 mgml solution for infusion | 合法藥品大搜索
Theoveralldurationoftreatmentwithintravenouslacosamideisatthephysician'sdiscretion;thereisexperiencefromclinicalstudieswithtwicedailyinfusionsof ...
Posology
The physician should prescribe the most appropriate formulation and strength according to weight and dose.
Lacosamide therapy can be initiated with either oral administration (either tablets or syrup) or intravenous administration (solution for infusion). Solution for infusion is an alternative for patients when oral administration is temporarily not feasible. The overall duration of treatment with intravenous lacosamide is at the physicians discretion; there is experience from clinical studies with twice daily infusions of lacosamide for up to 5 days in adjunctive therapy. Conversion to or from oral and intravenous administration can be done directly without titration. The total daily dose and twice daily administration should be maintained. Monitor closely patients with known cardiac conduction problems, on concomitant medications that prolong PR interval, or with severe cardiac disease (e.g. myocardial ischemia, heart failure) when lacosamide dose is hig...
Safety and Efficiency of Intravenous Push Lacosamide ... | 合法藥品大搜索
Safety of Intravenous Push Lacosamide Compared ... | 合法藥品大搜索
Safety of Intravenous Push Lacosamide Compared With ... | 合法藥品大搜索
756 | 合法藥品大搜索
IV Push Administration of Drugsa | 合法藥品大搜索
Intravenous (IV) Injection and Oral Solution | 合法藥品大搜索
Vimpat 10 mgml solution for infusion | 合法藥品大搜索
【維帕特 150毫克膜衣錠】1.四歲以上有或無次發性全身發作的局部癲癇發作病人的單一藥物治療。2.四歲以上之(1)複雜性局部癲癇發作(complex partial seizure)與 (2)單純或複雜性局部發作之合併有次發性全身發作(simple or complex partial seizure with secondary generalization)癲癇病人之輔助治療(add-on therapy)。
藥品名稱:維帕特150毫克膜衣錠許可證字號:衛部藥輸字第026286號許可證種類:製 劑適應症:1.四歲以上有或無次發性全身發作的...
【維帕特 100毫克膜衣錠】1.四歲以上有或無次發性全身發作的局部癲癇發作病人的單一藥物治療。2.四歲以上之(1)複雜性局部癲癇發作(complex partial seizure)與 (2)單純或複雜性局部發作之合併有次發性全身發作(simple or complex partial seizure with secondary generalization)癲癇病人之輔助治療(add-on therapy)。
藥品名稱:維帕特100毫克膜衣錠許可證字號:衛部藥輸字第026285號許可證種類:製 劑適應症:1.四歲以上有或無次發性全身發作的...
【維帕特糖漿 10毫克/毫升】Lacosamide適用於:1.四歲以上有或無次發性全身發作的局部癲癇發作病人的單一藥物治療。2.四歲以上之(1)複雜性局部癲癇發作(complex partial seizure)與 (2)單純或複雜性局部發作之合併有次發性全身發作(simple or complex partial seizure with secondary generalization)癲癇病人之輔助治療(add-on therapy)。
藥品名稱:維帕特糖漿10毫克/毫升許可證字號:衛部藥輸字第026892號許可證種類:製 劑適應症:Lacosamide適用於:1.四歲以上有或...
【癲控達膜衣錠8毫克】Fycompa適用於12歲以上成人及青少年患者局部癲癇發作併有或未併有續發型全身發作之治療。Fycompa適用於12歲以上成人及青少年患者原發型全身性強直陣攣癲癇發作併有原發性全身發作之輔助治療。
藥品名稱:癲控達膜衣錠8毫克許可證字號:衛部藥輸字第026330號許可證種類:製 劑適應症:Fycompa適用於12歲以上成人及青少年患...
【維帕特 200毫克膜衣錠】1.四歲以上有或無次發性全身發作的局部癲癇發作病人的單一藥物治療。2.四歲以上之(1)複雜性局部癲癇發作(complex partial seizure)與 (2)單純或複雜性局部發作之合併有次發性全身發作(simple or complex partial seizure with secondary generalization)癲癇病人之輔助治療(add-on therapy)。
藥品名稱:維帕特200毫克膜衣錠許可證字號:衛部藥輸字第026287號許可證種類:製 劑適應症:1.四歲以上有或無次發性全身發作的...
【維帕特 10毫克/毫升輸液溶液】1.四歲以上有或無次發性全身發作的局部癲癇發作病人的單一藥物治療。2.四歲以上之(1)複雜性局部癲癇發作(complex partial seizure)與 (2)單純或複雜性局部發作之合併有次發性全身發作(simple or complex partial seizure with secondary generalization)癲癇病人之輔助治療(add-on therapy)。
藥品名稱:維帕特10毫克/毫升輸液溶液許可證字號:衛部藥輸字第026283號許可證種類:製 劑適應症:1.四歲以上有或無次發性全身...
【必治癲注射液 10毫克/毫升】BRIVIACT注射液適用於16歲及以上局部癲癇發作病人的治療。(因尚未確立兒童病人使用BRIVIACT注射液的安全性)。
藥品名稱:必治癲注射液10毫克/毫升許可證字號:衛部藥輸字第027718號許可證種類:製 劑適應症:BRIVIACT注射液適用於16歲及以...